Grant: Discovery Grants Program - Individual
Université de Montréal
$48,000.00
Development and Update of Quantitative Pharmacology Concepts and Computational Models for a Better Understanding of Drug Fate and Action
EF 2024-25
Résumé
This research program bases on solid theoretical foundations to provide mathematical methodologies that help gaining better insights into the underlying mechanisms of the biological system, its transition between healthy and pathological conditions, and its action on/reaction with exogenous compounds. It addresses highly topical issues that became very important with the increasing role that mathematics play in the drug research area. It focuses on the development of advanced quantitative methodologies that are part of an integrative approach combining systems pharmacology with pharmacometrics (quantitative pharmacology). In fact, empirical culture, which historically prevailed in this field, is gradually fading to give more ground to these complementary or even alternative mathematical and computational tools, with the aim to rationalize and quantify drug development and use. Quantification of the complex relationship that exists between the drug, the patient biology and his drug behaviour is at the core of our interest. Whenever possible, concrete computational tools, nourished by the research components, are developed and bring an added value for the return on investment of public funds. This research program is fully dedicated to train a whole new generation of quantitative pharmacological scientists. It consists in three main lines, concerned with the development of integrative mathematical models, update of the most used pharmacokinetic metrics and the proposition of rational pharmacological strategies and minimally invasive approaches in a context of limited sampling, using physiological and pharmacokinetic modeling with mathematical analysis.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2020-05982
Name nom
Nekka, Fahima
Department département
Pharmacie, Faculté de - Pharmacie, Faculté de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
48000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
2960
Research subject group en
Applied mathematics
Research subject group fr
Mathématiques appliquées
Research subject en
Mathematical modelling
Research subject fr
Modélisation mathématique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Development and Update of Quantitative Pharmacology Concepts and Computational Models for a Better Understanding of Drug Fate and Action
Keywords
pharmacometrics; pharmacokinetics/pharmacodynamics; mathematical modeling and simulation; quantitative systems pharmacology; drug and systems related variability; sampling strategies; dosing regimen design; nonlinear kinetics; translational research; mobile health
Application summary
This research program bases on solid theoretical foundations to provide mathematical methodologies that help gaining better insights into the underlying mechanisms of the biological system, its transition between healthy and pathological conditions, and its action on/reaction with exogenous compounds. It addresses highly topical issues that became very important with the increasing role that mathematics play in the drug research area. It focuses on the development of advanced quantitative methodologies that are part of an integrative approach combining systems pharmacology with pharmacometrics (quantitative pharmacology). In fact, empirical culture, which historically prevailed in this field, is gradually fading to give more ground to these complementary or even alternative mathematical and computational tools, with the aim to rationalize and quantify drug development and use. Quantification of the complex relationship that exists between the drug, the patient biology and his drug behaviour is at the core of our interest. Whenever possible, concrete computational tools, nourished by the research components, are developed and bring an added value for the return on investment of public funds. This research program is fully dedicated to train a whole new generation of quantitative pharmacological scientists. It consists in three main lines, concerned with the development of integrative mathematical models, update of the most used pharmacokinetic metrics and the proposition of rational pharmacological strategies and minimally invasive approaches in a context of limited sampling, using physiological and pharmacokinetic modeling with mathematical analysis.